[go: up one dir, main page]

SG11202004935UA - Cell culture methods - Google Patents

Cell culture methods

Info

Publication number
SG11202004935UA
SG11202004935UA SG11202004935UA SG11202004935UA SG11202004935UA SG 11202004935U A SG11202004935U A SG 11202004935UA SG 11202004935U A SG11202004935U A SG 11202004935UA SG 11202004935U A SG11202004935U A SG 11202004935UA SG 11202004935U A SG11202004935U A SG 11202004935UA
Authority
SG
Singapore
Prior art keywords
cell culture
culture methods
methods
cell
culture
Prior art date
Application number
SG11202004935UA
Inventor
Valentine Chevallier
Nadine Kochanowski
Laetitia Malphettes
Vincent Adolphe Carol Cool
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60629439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11202004935U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of SG11202004935UA publication Critical patent/SG11202004935UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • C07K16/461Igs containing Ig-regions, -domains or -residues form different species
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11202004935UA 2017-12-01 2018-11-29 Cell culture methods SG11202004935UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17204978.5A EP3492582A1 (en) 2017-12-01 2017-12-01 Cell culture methods
PCT/EP2018/083010 WO2019106091A1 (en) 2017-12-01 2018-11-29 Cell culture methods

Publications (1)

Publication Number Publication Date
SG11202004935UA true SG11202004935UA (en) 2020-06-29

Family

ID=60629439

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004935UA SG11202004935UA (en) 2017-12-01 2018-11-29 Cell culture methods

Country Status (14)

Country Link
US (1) US11859203B2 (en)
EP (2) EP3492582A1 (en)
JP (1) JP7422072B2 (en)
KR (1) KR20200092348A (en)
CN (1) CN111417715B (en)
BR (1) BR112020010473A2 (en)
CA (1) CA3083680A1 (en)
EA (1) EA202091349A1 (en)
ES (1) ES2963653T3 (en)
HR (1) HRP20231175T1 (en)
HU (1) HUE063812T2 (en)
PL (1) PL3717631T3 (en)
SG (1) SG11202004935UA (en)
WO (1) WO2019106091A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN112391350A (en) * 2020-10-30 2021-02-23 北京双鹭药业股份有限公司 Screening and culturing method for high-efficiency expression anti-EGFR monoclonal antibody cells
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
EP4166651A1 (en) 2021-10-18 2023-04-19 Evonik Operations GmbH Methods and composition to increase cellular glutathione level
WO2023067626A1 (en) * 2021-10-20 2023-04-27 Dr. Reddy's Laboratories Limited A cell culture process to produce an antibody composition
WO2023157970A1 (en) * 2022-02-21 2023-08-24 中外製薬株式会社 Perfusion culture method
CN119546744A (en) * 2022-07-25 2025-02-28 味之素株式会社 Cell culture medium

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
EP0953041A4 (en) 1996-08-30 2003-01-29 Life Technologies Inc Serum-free mammalian cell culture medium, and uses thereof
CA2346700A1 (en) * 1998-10-09 2000-04-20 Ajinomoto Co., Inc. Cysteine derivatives
KR20050070512A (en) 2003-12-30 2005-07-07 삼성정밀화학 주식회사 Cell culture method and serum free meia for improved production of recombinant protein
EP2500414A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
CA2842964A1 (en) * 2006-09-13 2008-03-20 Abbvie Inc. Cell culture improvements
LT3330370T (en) 2010-04-26 2021-06-10 Novartis Ag Process for cultivation of cho cells
WO2013158275A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
SG11201609980TA (en) 2014-06-18 2016-12-29 Medimmune Llc Cell culture methods and media comprising n-acetylcysteine
US11220668B2 (en) * 2016-04-28 2022-01-11 Merck Patent Gmbh Method for reducing the trisulfide level in proteins
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods

Also Published As

Publication number Publication date
PL3717631T3 (en) 2024-03-04
CN111417715A (en) 2020-07-14
US20200308536A1 (en) 2020-10-01
JP2021503938A (en) 2021-02-15
EP3717631B1 (en) 2023-08-30
WO2019106091A1 (en) 2019-06-06
ES2963653T3 (en) 2024-04-01
EP3492582A1 (en) 2019-06-05
EA202091349A1 (en) 2020-08-20
BR112020010473A2 (en) 2020-11-24
KR20200092348A (en) 2020-08-03
US11859203B2 (en) 2024-01-02
HUE063812T2 (en) 2024-02-28
HRP20231175T1 (en) 2024-01-19
EP3717631A1 (en) 2020-10-07
CN111417715B (en) 2024-08-27
JP7422072B2 (en) 2024-01-25
CA3083680A1 (en) 2019-06-06
EP3717631C0 (en) 2023-08-30

Similar Documents

Publication Publication Date Title
GB201611982D0 (en) Cell culture
SG11201703493SA (en) Cell culture insert
SG10202005898PA (en) Cell culture medium
SG11201800694QA (en) Cell culture container
GB201509202D0 (en) Semi-static cell culture
SG11201609916RA (en) Culture method and cell mass
LT3365107T (en) Cell culture
GB201712733D0 (en) Methods & cells
SG11201706090SA (en) Cell culturing method and kit
SG11202004935UA (en) Cell culture methods
GB201715930D0 (en) Cell Culture Medium
SG11202005559VA (en) Improved cell culture device
IL261999A (en) Cell culture process
PL3287521T3 (en) Cell culture
PL3630946T3 (en) Cell culture methods
GB201608764D0 (en) Novel cell culture
HK40114294A (en) Cell culture methods
SG11201800503YA (en) Stem cell culturing method
EP3260528A4 (en) Cell culture apparatus
GB201715518D0 (en) Cell cultivation methods
SG10202010002RA (en) Cell culture
GB201711892D0 (en) Improved culture methods
TWI563082B (en) Cell culture device
GB201608847D0 (en) Improved Cell Culture using beads
GB201421342D0 (en) Cell culture